FDA's 2016 New Dietary Ingredient Draft Guidance - Food and Drug Law Institute (FDLI)
FDA's 2016 New Dietary Ingredient Draft Guidance has been updated, clarifying requirements for NDI notifications. This affects supplement brands, contract manufacturers, private-label sellers, and ingredient suppliers who must ensure their NDIs are properly notified to FDA.
Aforeworn detected this change in the Dietary-Supplement Labeling (FDA) space on July 6, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated High urgency. Supplement brands, contract manufacturers, private-label sellers, ingredient suppliers should confirm how it applies to their specific situation before acting. There is a time constraint attached: Ongoing; FDA expects compliance immediately. For new products, notification must be submitted 75 days before marketing.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Dietary-Supplement Labeling (FDA) continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
FDA released updated draft guidance on New Dietary Ingredients (NDIs), emphasizing that any dietary supplement containing a new dietary ingredient must submit a premarket notification unless the ingredient is present in the food supply as an article used for food in a form in which the food has not been chemically altered.
Who it affects
Supplement brands, contract manufacturers, private-label sellers, ingredient suppliers
What you must do
Review all dietary supplement products for new dietary ingredients and submit NDI notifications to FDA at least 75 days before marketing, or ensure the ingredient qualifies for an exemption.
Deadline
Ongoing; FDA expects compliance immediately. For new products, notification must be submitted 75 days before marketing.
Never miss a change like this again
Aforeworn watches Dietary-Supplement Labeling (FDA) around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Dietary-Supplement Labeling (FDA)
- Warning Letters | FDA
- FDA Advisory No.2026-0735 || Public Health Warning on the Presence of Sildenafil Citrate in TURBO Maca and Clavo Huasca Dietary Supplement Capsules for Men with Lot Number 24TRB1102 - Food and Drug Administration - fda.gov.ph
- FDA Advisory No.2026-0162-A || Lifting the Advisory on the Registered Food Product LUXE SKIN BEAUTY TALKS L’ANNA Premium Oral Sunblock + Stem Cell Dietary Supplement “Public Health Warning Against the Purchase and Consumption of the Unregis - fda.gov.ph
- The Dietary Supplement Industry in the Time of Trump: Potential Opportunities and Pitfalls - Food and Drug Law Institute (FDLI)
- 60 Degrees Pharmaceuticals Signs Exclusive Patent License Agreement with Florida State University for Non-Prescription Use of Australian Chestnut Extract as a Botanical Supplement - GlobeNewswire